Gene and protein expression changes in response to normoxic perfusion in mouse hearts

Journal of Pharmacological and Toxicological Methods

Volumn 57, Issue 2, 2008, Pages 145-154

  Faragó, Nóra ^a   Kocsis, Gabriella F ^b   Fehér, Liliána Z ^a   Csont, Tamás ^b   Hackler Jr , László ^a   Varga Orvos, Zoltán ^a   Csonka, Csaba ^b   Kelemen, János Z ^a   Ferdinandy, Péter ^b   Puskás, László G ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Global gene expression; Heart model; Isolated heart; Mouse heart; Normoxic perfusion

Indexed keywords

ALPHA7 INTEGRIN; CASEIN KINASE II; CREATINE KINASE; DISINTEGRIN; GELATINASE A; GELATINASE B; KETOHEXOKINASE; LACTATE DEHYDROGENASE; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; MESSENGER RNA; METALLOPROTEINASE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; VOLTAGE DEPENDENT ANION CHANNEL 1;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE EXPRESSION PROFILING; GENE REPRESSION; HEART MUSCLE PERFUSION; ISOLATED HEART; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION;

ANIMALS; CREATINE KINASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; L-LACTATE DEHYDROGENASE; MALE; MICE; MICE, INBRED STRAINS; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXYGEN; PERFUSION; PROTEIN BIOSYNTHESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC;

MUS;

EID: 40649106431     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2008.01.001     Document Type: Article

References (52)

1. Andres J., Sharma H.S., and Sassen L.M. Reperfusion after brief repetitive ischemia in porcine myocardium does not alter expression of creatine kinase MM or mitochondrial ATPase mRNAs. Journal of Physiology and Pharmacology 44 (1993) 333-344
2. Anflous K., Armstrong D.D., and Craigen W.J. Altered mitochondrial sensitivity for ADP and maintenance of creatine-stimulated respiration in oxidative striated muscles from VDAC1-deficient mice. Journal of Biological Chemistry 276 (2001) 1954-1960
3. Anguita J., Chalfant M.L., Civan M.M., and Coca-Prados M. Molecular cloning of the human volume-sensitive chloride conductance regulatory protein, pICln, from ocular ciliary epithelium. Biochemical and Biophysical Research Communication 208 (1995) 89-95
4. Bais R., James H.M., Rofe A.M., and Conyers R.A. The purification and properties of human liver ketohexokinase. A role for ketohexokinase and fructose-bisphosphate aldolase in the metabolic production of oxalate from xylitol. Biochemical Journal 230 (1985) 53-60
5. Carter N.M., Ali S., and Kirby J.A. Endothelial inflammation: the role of differential expression of N-deacetylase/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate. Journal of Cell Science 116 (2003) 3591-3600
6. Cave A.C., Brewer A.C., Narayanapanicker A., Ray R., Grieve D.J., Walker S., et al. NADPH oxidases in cardiovascular health and disease. Antioxidants and Redox Signalling 8 (2006) 691-728
7. Chiu P.Y., and Ko K.M. Schisandrin B protects myocardial ischemia-reperfusion injury partly by inducing Hsp25 and Hsp70 expression in rats. Mollecular and Cellular Biochemistry 266 (2004) 139-144
8. Chow A.K., Cena J., and Schulz R. Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature. British Journal of Pharmacology 152 (2007) 189-205
9. Clements-Jewery H., Hearse D.J., and Curtis M.J. The isolated blood-perfused rat heart: an inappropriate model for the study of ischaemia- and infarction-related ventricular fibrillation. British Journal of Pharmacology (2002) 1089-1099
10. Csont T., Viappiani S., Sawicka J., Slee S., Altarejos J.Y., Batinic-Haberle I., et al. The involvement of superoxide and iNOS-derived NO in cardiac dysfunction induced by pro-inflammatory cytokines. Journal of Molecular and Cellular Cardiology 39 (2005) 833-840
11. Curtis M.J. Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation. Cardiovascular Research 39 (1998) 194-215
12. Fedak P.W., Moravec C.S., and McCarthy P.M. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy. Circulation 113 (2006) 238-245
13. Ferdinandy P., Panas D., and Schulz R. Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts. American Journal of Physiology 276 (1999) H1861-H1867
14. Ferdinandy P., and Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. British Journal of Pharmacology 138 (2003) 532-543
15. Ferdinandy P., Schulz R., and Baxter G.F. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacological Reviews 59 (2007) 418-458
16. Gao C.Q., Sawicki G., Suarez-Pinzon W.L., Csont T., Wozniak M., Ferdinandy P., et al. Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovascular Research 57 (2003) 426-433
17. Ginsburg D. Identifying novel genetic determinants of hemostatic balance. Journal of Thrombosis and Haemostasis 3 (2005) 1561-1568
18. Giricz Z., Csonka C., Onody A., Csont T., and Ferdinandy P. Role of cholesterol-enriched diet and the mevalonate pathway in cardiac nitric oxide synthesis. Basic Research in Cardiology 98 (2003) 304-310
19. Giricz Z., Lalu M.M., Csonka C., Bencsik P., Schulz R., and Ferdinandy P. Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition. Journal of Pharmacology and Experimental Therapeutic 316 (2006) 154-161
20. Hearse D.J., Richard V., Yellon D.M., and Kingma Jr. J.G. Evolving myocardial infarction in the rat in vivo: an inappropriate model for the investigation of drug-induced infarct size limitation during sustained regional ischaemia. Journal of Cardiovascular Pharmacology 11 (1988) 701-710
21. Holmborn K., Ledin J., Smeds E., Eriksson I., Kusche-Gullberg M., and Kjellén L. Heparan sulfate synthesized by mouse embryonic stem cells deficient in NDST1 and NDST2 is 6-O-sulfated but contains no N-sulfate groups. Journal of Biological Chemistry 279 (2004) 42355-42358
22. Infanger D.W., Sharma R.V., and Davisson R.L. NADPH oxidases of the brain: distribution, regulation, and function. Antioxidant and Redox Signalling 8 (2006) 1583-1596
23. Karaca P., Konuralp C., Enc Y., Suzer A., Sokullu O., Ayoglu U., et al. Cardioprotective effect of aprotinin on myocardial ischemia/reperfusion injury during cardiopulmonary bypass. Circulation Journal 70 (2006) 1432-1436
24. Kurohara K., Komatsu K., Kurisaki T., and Masuda. Essential roles of Meltrin beta (ADAM19) in heart development. Developments in Biologicals 267 (2004) 14-28
25. Kutukculer N., Genel F., Aksu G., Karapinar B., Ozturk C., Cavusoglu C., et al. Cutaneous leukocytoclastic vasculitis in a child with interleukin-12 receptor beta-1 deficiency. Journal of Pediatrics 148 (2006) 407-409
26. Machado L.S., Kozak A., Ergul A., Hess D.C., Borlongan C.V., and Fagan S.C. Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neuroscience 7 (2006) 56
27. Mastrodimou N., Lambrou G.N., and Thermos K. Effect of somatostatin analogues on chemically induced ischaemia in the rat retina. Naunyn Schmiedeberg's Archives of Pharmacology 371 (2005) 44-53
28. Mayer U., Saher G., Fassler R., Bornemann A., Echtermeyer F., von der Mark H., et al. Absence of integrin alpha 7 causes a novel form of muscular dystrophy. Nature Genetics 17 (1997) 318-323
29. Mertens A., and Holvoet P. Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB Journal 15 (2002) 2073-2084
30. Miyashita T., Kubota I., Yamaki M., Watanabe T., Yamauchi S., and Tomoike H. 4-aminopyridine inhibits the occurrence of ventricular fibrillation but not ventricular tachycardia in the reperfused, isolated rat heart. Japanese Circulation Journal 64 (2000) 602-605
31. Mohlke K.L., Purkayastha A.A., Westrick R.J., Smith P.L., Petryniak B., Lowe J.B., et al. Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase. Cell 96 (1999) 111-120
32. Mori S., Gibson G., and McTiernan C.F. Differential expression of MMPs and TIMPs in moderate and severe heart failure in a transgenic model. Journal of Cardiac Failure 12 (2006) 314-325
33. Onody A., Zvara A., Hackler Jr. L., Vigh L., Ferdinandy P., and Puskas L.G. Effect of classic preconditioning on the gene expression pattern of rat hearts: a DNA microarray study. FEBS Letters 536 (2003) 35-40
34. Palotas A., Puskas L.G., Kitajka K., Palotas M., Molnar J., Pakaski M., et al. The effect of citalopram on gene expression profile of Alzheimer lymphocytes. Neurochemical Research 29 (2004) 1563-1570
35. Puskás L.G., Nagy Z.B., Giricz Z., Onody A., Csonka C., Kitajka K., et al. Cholesterol diet-induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microarray study. FEBS Letters 562 (2004) 99-104
36. Puskás L.G., Zvara A., Hackler Jr. L., Micsik T., and van Hummelen P. Production of bulk amounts of universal RNA for DNA microarrays. Biotechniques 33 (2002) 898-900 (902, 904)
37. Ravingerova T., Pancza D., Ziegelhoffer A., and Styk J. Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rat heart: the role of alpha-adrenergic stimulation and K(ATP) channels. Physiological Research 51 (2005) 109-119
38. Ravingerová T., Tribulová N., Slezák J., and Curtis M.J. Brief, intermediate and prolonged ischemia in the isolated crystalloid perfused rat heart: relationship between susceptibility to arrhythmias and degree of ultrastructural injury. Journal of Molecular and Cellular Cardiological 27 (1995) 1937-1951
39. Schomisch S.J., Murdock D.G., Hedayati N., Carino J.L., Lesnefsky E.J., and Cmolik B.L. Cardioplegia prevents ischemia-induced transcriptional alterations of cytoprotective genes in rat hearts: a DNA microarray study. Journal of Thoracic and Cardiovascular Surgery 130 (2005) 1151
40. Sobki S.H., Saadeddin S.M., and Habbab M.A. Cardiac markers used in the detection of myocardial injury. Saudi Medical Journal 21 (2000) 843-846
41. So{double acute}ti C., Nagy E., Giricz Z., Vígh L., Csermely P., and Ferdinandy P. Heat shock proteins as emerging therapeutic targets. British Journal of Pharmacology 146 (2005) 769-780
42. Spinale F.G. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circulation Research 90 (2002) 520-530
43. Sutherland F.J., and Hearse D.J. The isolated blood and perfusion fluid perfused heart. Pharmacological Research 41 (2000) 613-627
44. Thorpe C., and Kim J.J. Structure and mechanism of action of the acyl-CoA dehydrogenases. FASEB Journal 9 (1995) 718-725
45. Wan X.L., Chen S., and Sears M. Cloning and functional expression of a swelling-induced chloride conductance regulatory protein, plCln, from rabbit ocular ciliary epithelium. Biochemistry and Biophysics Research Communication 239 (1997) 692-696
46. Werb Z., and Chin J.R. Extracellular matrix remodeling during morphogenesis. Annals of the New York Academy of Sciences 857 (1998) 110-118
47. Wolfe M.S., De Los Angeles J., Miller D.D., Xia W., and Selkoe D.J. Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease. Biochemistry 38 (1999) 11223-11230
48. Xu D., Li Y., Wang J., Davey A.K., Zhang S., and Evans A.M. The cardioprotective effect of isosteviol on rats with heart ischemia-reperfusion injury. Life Sciences 80 (2006) 269-274
49. Yan L., Vatner D.E., Kim S.J., Ge H., Masurekar M., Massover W.H., et al. Autophagy in chronically ischemic myocardium. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 13807-13812
50. Yang Y.H., Dudoit S., Luu P., Lin D.M., Peng V., Ngai J., et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Research 30 (2002) e15
51. Yoshida T., Maulik N., Engelman R.M., and Ho Y.S. Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circulation Research 86 (2000) 264-269
52. Zhang J., Zhang W., Zou D., Chen G., Wan T., Zhang M., et al. Cloning and functional characterization of ACAD-9, a novel member of human acyl-CoA dehydrogenase family. Biochemical and Biophysical Research Communication 297 (2002) 1033-1042